MarkMFusterMD
Pulmonology • San Diego, CACritical Care Medicine
Associate Professor, Medicine, UCSD School of Medicine
Dr. Fuster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 800-926-8273Fax+1 619-543-3183
Education & Training
University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1993 - 1996
David Geffen School of Medicine at UCLAClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2026- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Early Diagnosis and Treatment of Sleep Disordered Breathing in Lung Cancer Start of enrollment: 2017 Nov 17
Publications & Presentations
PubMed
- Diversity of human salivary heparan sulfate.Charlotte B Spliid, Sanjay Mehta, Mark M Fuster, Cameron Martino, Claire L Morris
Glycobiology. 2024-12-10 - 1 citationsGlycocalyx transduces membrane leak in brain tumor cells exposed to sharp magnetic pulsing.Scott C Johns, Purva Gupta, Yi-Hung Lee, James Friend, Mark M Fuster
Biophysical Journal. 2023-11-21 - 3 citationsGenetic alteration of heparan sulfate in CD11c + immune cells inhibits inflammation and facilitates pathogen clearance during influenza A virus infection.So Young Kim, Purva Gupta, Scott C Johns, Elina I Zuniga, John R Teijaro
Scientific Reports. 2022-03-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
